menu
    • menu

    Company profile for Norgine

    NEW Drugs in Dev: 18
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Norgine is a leading European specialist pharmaceutical company that has been bringing transformative medicines to patients for over a century. Our commitment to transforming people's lives drives everything we do and our European experience, fully integrated infrastructure and exceptional partnership approach enables us to quickly apply creative solutions to bring life-changing medicines to patients that they may not otherwis...
    Norgine is a leading European specialist pharmaceutical company that has been bringing transformative medicines to patients for over a century. Our commitment to transforming people's lives drives everything we do and our European experience, fully integrated infrastructure and exceptional partnership approach enables us to quickly apply creative solutions to bring life-changing medicines to patients that they may not otherwise be able to access. Norgine is proud to have helped 22 million patients around the world in 2019 and generated €419 million in net product sales, a growth of 6% over 2018.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NorgineNetherlands1 Flag
    Country
    Country
    Netherlands
    Address
    Address
    Norgine BV Antonio Vivaldistraat 150 1083 HP Amsterdam
    Telephone
    Telephone
    +31 20 567 0900
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://norgine.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/norgine
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/norgine

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Bio-Europe Spring

    Bio-Europe Spring

    Not Confirmed

    envelop Contact Supplier

    Bio-Europe Spring

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Swissmedic Approves PEDMARQSI to Prevent Kids' Hearing loss
    Swissmedic Approves PEDMARQSI to Prevent Kids' Hearing loss

    26 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/norgine-announces-swissmedic-approval-of-pedmarqsi-for-the-prevention-of-cisplatin-induced-hearing-loss-in-children-302725193.html

    PR NEWSWIRE
    26 Mar 2026
    Share Share
    Spineguard Completes Norgine And Harbert European Growth Bond
    Spineguard Completes Norgine And Harbert European Growth Bond

    25 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-25/spineguard-announces-the-full-settlement-of-the-norgine-and-harbert-european-growth-bond-issues

    PHARMIWEB
    25 Mar 2026
    Share Share
    Norgine Invests £23M In Welsh Medicine Manufacturing Expansion
    Norgine Invests £23M In Welsh Medicine Manufacturing Expansion

    05 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/norgine-announces-23-million-new-investment-as-part-of-more-than-50-million-committed-to-expanding-medicines-manufacturing-in-wales-302704503.html

    PR NEWSWIRE
    05 Mar 2026
    Share Share
    Norgine Gets Positive CHMP Opinion for Mavorixafor in EU
    Norgine Gets Positive CHMP Opinion for Mavorixafor in EU

    27 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/norgine-welcomes-positive-chmp-opinion-recommending-approval-of-mavorixafor-in-the-european-union-for-whim-syndrome-302698935.html

    PR NEWSWIRE
    27 Feb 2026
    Share Share
    Vir Biotech Grants Norgine Exclusive License For Hepatitis Delta
    Vir Biotech Grants Norgine Exclusive License For Hepatitis Delta

    16 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251216955463/en/Vir-Biotechnology-Grants-Norgine-Exclusive-Commercial-License-to-Chronic-Hepatitis-Delta-Treatment-Candidate-in-Europe-Australia-New-Zealand-Including-Global-Cost-Sharing-Agreement-for-Ongoing-ECLIPSE-Clinical-Development-Program

    BUSINESSWIRE
    16 Dec 2025
    Share Share
    Norgine Completes Acquisition of Theravia
    Norgine Completes Acquisition of Theravia

    14 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/norgine-completes-acquisition-of-theravia-302529332.html

    PR NEWSWIRE
    14 Aug 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search